谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

AZD8186, a potent and selective inhibitor of PI3Kβ/δ, as monotherapy and in combination with abiraterone acetate plus prednisone (AAP), in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)

J.S. de Bono, A. Hansen,A.D. Choudhury,N. Cook,E.I. Heath,C. Higano,M. Linch,J. Martin-Liberal,D.E. Rathkopf,K.B. Wisinski,S. Barry,E. de Bruin,W. Brugger,S. Colebrook,T. Klinowska, M. Moschetta, P.G.S. Mortimer,L.L. Siu, G. Shapiro

Annals of Oncology（2018）

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要